Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies#Akeso039s #Results #Strengthening…
Tag: Akeso039s
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer#Akeso039s #Penpulimab #Receives #NMPA #Approval #FirstLine…